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Abstract 
Background: This study explores the factor structure of the Indonesian version of the GHQ-12 based on several 
theoretical perspectives and determines the threshold for optimum sensitivity and specificity. Through a focus group 
discussion, we evaluate the practicality of the GHQ-12 as a screening tool for mental health problems among adult 
primary care patients in Indonesia.
Methods: This is a prospective study exploring the construct validity, criterion validity and reliability of the GHQ-12, 
conducted with 676 primary care patients attending 28 primary care clinics randomised for participation in the study. 
Participants’ GHQ-12 scores were compared with their psychiatric diagnosis based on face-to-face clinical interviews 
with GPs using the CIS-R. Exploratory and Confirmatory Factor Analyses determined the construct validity of the GHQ-
12 in this population. The appropriate threshold score of the GHQ-12 as a screening tool in primary care was deter-
mined using the receiver operating curve. Prior to data collection, a focus group discussion was held with research 
assistants who piloted the screening procedure, GPs, and a psychiatrist, to evaluate the practicality of embedding 
screening within the routine clinic procedures.
Results: Of all primary care patients attending the clinics during the recruitment period, 26.7% agreed to participate 
(676/2532 consecutive patients approached). Their median age was 46 (range 18–82 years); 67% were women. The 
median GHQ-12 score for our primary care sample was 2, with an interquartile range of 4. The internal consistency of 
the GHQ-12 was good (Cronbach’s α = 0.76). Four factor structures were fitted on the data. The GHQ-12 was found 
to best fit a one-dimensional model, when response bias is taken into consideration. Results from the ROC curve 
indicated that the GHQ-12 is ‘fairly accurate’ when discriminating primary care patients with indication of mental 
disorders from those without, with average AUC of 0.78. The optimal threshold of the GHQ-12 was either 1/2 or 2/3 
point depending on the intended utility, with a Positive Predictive Value of 0.68 to 0.73 respectively. The screening 
procedure was successfully embedded into routine patient flow in the 28 clinics.
Conclusions: The Indonesian version of the GHQ-12 could be used to screen primary care patients at high risk of 
mental disorders although with significant false positives if reasonable sensitivity is to be achieved. While it involves 
additional administrative burden, screening may help identify future users of mental health services in primary care 
that the country is currently expanding.
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Background
In 2015, Indonesia had only 773 psychiatrists for 250 
million residents [1]. This shortage of specialist mental 
health professionals is shared by most Low- and Mid-
dle-Income Countries (LMICs). This is reflected in the 
treatment gap and low proportion of people who receive 
adequate mental health care for their needs. While the 
median worldwide Treatment Gap for psychosis is 32.2% 
[2], the treatment gap in Indonesia is more than 90% [3]. 
Mental health problems are estimated to be present in 
around 20–36% of patients attending primary care set-
tings and when untreated, result in significant suffer-
ing and growing healthcare costs [4, 5]. Improving ways 
to identify people at risk of mental health problems is a 
feasible strategy to help bridge the Treatment Gap and 
reduce their suffering [6].
Embedding a screening procedure into primary care 
could help early identification, intervention, and pre-
vention of common mental disorders, including anxiety 
and depression [7]. Screening scales allow for a more 
systematic assessment of self-reported mental health 
problems. For a screening procedure to be effective, a 
reliable screening instrument is necessary, and its opti-
mal threshold needs to be determined. Screening alone 
cannot and will not improve the outcomes for common 
mental disorders such as depression, if resources for 
effective intervention must also be in place [8]. In Indo-
nesia, mental health services are increasingly provided at 
zero or very low costs in primary care following the sys-
tematic introduction of the World Health Organization 
(WHO) Mental Health Gap Action Programme to 10,000 
primary care clinics [9].
The General Health Questionnaire (GHQ) is a self-
administered screening tool designed to detect current 
state mental disturbances and disorders in primary care 
setting [10]. The GHQ has been translated into 38 lan-
guages since its development, indicating its face valid-
ity across cultures [11]. While the GHQ was originally 
developed as a 60-item questionnaire, several abridged 
versions (30-item, 28-item, 20-item, and 12-item) are 
currently available. The 12-item version was adopted as 
a screening tool in a multi-country World Health Organi-
zation (WHO) study of mental disorders in primary care 
setting, as it was considered the best validated among 
similar inventories [12–14].
The twelve-item General Health Questionnaire (GHQ-
12) is intended to screen for general (non-psychotic) 
mental health problems among primary care patients 
[12]. Items on the GHQ-12 are rated on a 4-point scale 
using a timeframe of “in the last two weeks.” There are 
three ways of scoring the GHQ-12: the bimodal GHQ 
scoring method (0-0-1-1) recommended by the test 
authors for use in clinical settings; and the Likert scor-
ing method (0-1-2-3) which is commonly used in 
research, and the C-GHQ scoring method where posi-
tively phrased items are scored (0-0-1-1) and negatively 
phrased items (0-1-1-1).
A review of international validity studies of GHQ-12 
conducted 20  years ago, including in LMICs, reported 
that the optimal threshold varied from 1/2 to 6/7, with 
the most common cut-off being 2/3 [12]. Considering 17 
more international studies revealed a range of thresholds 
from 0/1 to 5/6 [15]. Table 1 shows later studies, and their 
distribution of thresholds [4, 7, 16–36]. These differences 
may be the result of varying prevalence rates of mental 
disorders and comorbidity, as well as the populations in 
which the scale was administered and cultural influences 
[37].
The first GHQ-12 validity and reliability study in Indo-
nesia was published in 2006, where GHQ-12 was com-
pared against Symptom Checklist (SCL-90) as the gold 
standard, in a community-based prevalence study [38]. 
A Confirmatory Factor Analysis (CFA) found the Indo-
nesian version of the instrument to have two factors: 
psychological distress and social dysfunction. Since then, 
the Indonesian language version of the GHQ-12 has been 
extensively used in numerous research studies.
A more recent study examined the validity of the 
GHQ-12 as a screening tool for Adjustment Disorder in 
Indonesian primary care setting [39]. This study shows 
that the GHQ-12 is valid and reliable for use with adjust-
ment disorder, Cronbach’s α = 0.863 for Likert scoring 
and 0.841 for bimodal scoring. For Adjustment Disorder, 
sensitivity and specificity for GHQ-12 were.81 and 0.62 
(for the optimum cut-off point ≥ 11 in Likert scoring 
method), 0.81 and 0.57 (for the optimum cut-off point ≥ 2 
in bimodal scoring method). The study further con-
ducted CFAs of the different scoring methods, each find-
ing agreement with different existing theoretical models.
This study aims to examine the psychometrics and 
practicality of using GHQ-12 to screen for common 
mental health problems among Indonesian adult pri-
mary care patients. The feasibility of the screening pro-
cedure will be evaluated by embedding it into routine 
patient flow for 2  weeks in a pilot study, followed by a 
focus group discussion with stakeholders involved in the 
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implementation. Cronbach’s alpha will indicate the scale’s 
internal consistency. CFAs will be used to determine con-
struct validity as used in previous studies [40]. Receiver 
Operating Characteristic (ROC) curves have been widely 
used to describe and compare the performance of diag-
nostic algorithms [41] and will be used to determine the 
most appropriate threshold score.
Methods
Context
There are approximately 10,000 state-owned primary 
care clinics in Indonesia, providing free access to medical 
and dental care for residents of each clinic’s catchment 
area. These clinics, called Puskesmas, also provide care 
at a nominal fee for non-residents. This study recruited 
participants from 28 Puskesmas in Yogyakarta, Indo-
nesia, as part of a pre-study of a cluster randomised 
controlled trial [9]. These 28 Puskesmas provide men-
tal health services. All Puskesmas in the province have 
received ISO accreditation standardising their patient 
flow and administrative procedures, making it possible to 
embed a uniform screening procedure across the clinics.
Design
This is a cross sectional study conducted to test the valid-
ity and screening accuracy of the GHQ-12 and determine 
the point at which the balance between sensitivity and 
specificity is optimised. This study piloted the recruit-
ment procedures for a trial examining the clinical and 
cost-effectiveness of two mental health care frameworks 
Table 1 A Sample of GHQ-12 Threshold Studies on Various Clinical Populations after 1998
Author Country Sample Threshold Scoring
Hardy [22] England Health care employees 3/4 GHQ-12
Kuruvilla [27] India Primary care patients 2/3 GHQ-12
Bhui [17] England Punjabi primary care patients 2/3 GHQ-12
Aydin [16] Turkey Tubercolosis and chronic obstructive pulmonary 
disease patients
3/4 Tubercolosis
5/6 COPD
GHQ-12
Cano [18] USA Veterans 1/2 GHQ-12
Daradkeh [20] UAE Undergraduates 15/16 Likert
Donath [21] Australia General population 3/4
0/1
C-GHQ
GHQ-12
Makowska [29] Poland Working adults 2/3 GHQ-12
Holi [23] Finland General population 3/4 GHQ-12
McKenzie [31] Australia Gulf war veterans 1/2 GHQ-12
Picardi [33] Italy Dermatology patients 3/4 GHQ-12
Martin [30] UK Individuals with facial disfigurement 0/1 C-GHQ and GHQ-12
Navarro [32] Spain Postnatal women 4/5 GHQ-12
Schmitz [13] Germany Primary care patients 11/12 Likert
Shelton [35] England Postnatal women 4/5
14/15
GHQ-12
Likert
Krespi Boothby [26] Turkey Breast cancer patients 1/2 affective disor-
ders
1/2 generalised anxi-
ety disorder
3/4 major depression
GHQ-12
Yusoff [36] Malaysia Medical students 3/4 GHQ-12
Baksheev [7] Australia High school students 9/10 for males
10/11 for females
Likert
Caraveo-Anduaga [19] Mexico Primary care patients 2/3 GHQ-12
Cornelius (2013) The Netherlands Disability claimants 19/20 Likert
John [24] India General population 3/4 GHQ-12
Kim [25] Korea General population 2/3 GHQ-12
Lundin [28] Sweden General population 11/12
5/6
1/2
Likert
C-GHQ
GHQ-12
Ruiz [34] Colombia Undergraduates; female adults; psychiatric patients 2/3
11/12
GHQ-12
Likert
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for primary care [9]. A pilot study was conducted in June 
2016 to test the screening procedure.
Ethics
Ethics approval for the study and larger trial was granted 
by the University of Cambridge Psychology Research 
Ethics Committee (reference number PRE.2015.108) and 
Universitas Gadjah Mada (reference number 1237/SD/
PL.03.07/IV/2016). Trial insurance further covers inves-
tigators and research participants (University of Cam-
bridge Trial Insurance reference number 609/M/C/1510). 
Permission to conduct research at the Province of Yog-
yakarta including its all five districts was obtained from 
the Provincial Government Office (reference number 
070/REG/V/625/5/2016). Additional permits were also 
obtained from each of the five districts. Ethics approval 
from individual clinics (Puskesmas) were not required 
as all clinics are funded and managed by district govern-
ments. The trial which this study was embedded in has 
been registered with clinicaltrials.gov since 25 February 
2016, NCT02700490.
Participants
Participants were primary care attendees recruited over a 
period of 2 weeks in December 2016. These patients pre-
sent with physical ailments at the adult general care clinic 
of the Puskesmas. Patients pick up a queue number and 
a GHQ-12 form, which they self-completed while wait-
ing for routine blood pressure checks. Patients were then 
invited to take part in the study regardless of their GHQ-
12 score. From 2532 consecutive primary care patients 
who completed the GHQ-12, 26.7% (676) consented to 
additional in-depth psychiatric interview. The interviews 
were conducted by a general medical practitioner (GP) 
blinded to their patients’ GHQ-12 score.
Measures
General Health Questionnaire (GHQ‑12)
The primary measure being assessed for its screening 
accuracy is the Bahasa Indonesia version of the GHQ-
12. Prior to patient recruitment, the lead author (SGA) 
reviewed the items with the 28 clinicians from partici-
pating sites to ensure content and semantic validity. The 
same version had been used in previous validation stud-
ies with various clinical populations. In the Bahasa Indo-
nesia version, items 2, 5, 6, 9, 10, and 11 are negatively 
phrased. This study took place in ‘real life’ clinical setting, 
suggesting the appropriateness of the bimodal scoring 
method (0-0-1-1). As this study aims to examine the ade-
quacy of the GHQ-12 as a screening tool, lifetime diag-
noses were not taken into consideration. Instead, current 
mental health status was evaluated.
Clinical Interview Schedule‑Revised (CIS‑R)
For the evaluation of mental health, GPs used the Clini-
cal Interview Schedule-Revised (CIS-R) [42], following 
the protocol of similar validity studies in Italy, England, 
Brazil, and Chile [15]. The CIS-R [42] is a fully structured 
diagnostic instrument that was developed from an exist-
ing instrument, the Clinical Interview Schedule (CIS), 
designed to be used by clinically experienced interview-
ers [43]. The CIS was revised and developed into a fully 
structured interview to increase standardisation and to 
make it suitable to be used by trained lay interviewers in 
assessing minor psychiatric morbidity in the community, 
general hospital, occupational and primary care research. 
As the CIS-R specifically diagnoses mood and anxiety 
disorders, participants with indication of other disorders 
(psychosis, sleep disorders, dementia) were asked addi-
tional questions which enabled the interviewers to estab-
lish an ICD-10 diagnosis.
For our sample, interviews were conducted by GPs. The 
psychiatric diagnostic criteria of the ICD-10 are widely 
used in the Indonesian health system as the Indonesian 
manual for diagnosing psychiatric disorders (Pedoman 
Panduan Diagnosa Gangguan Jiwa) released in 1993 and 
used by medical doctors and psychologists, was a transla-
tion and adaptation of the ICD-10 released by the WHO 
in 1992.
Data analysis
IBM SPSS version 24.0 and IBM SPSS Amos version 24.0 
were used to conduct the Confirmatory Factor Analysis 
(CFA) and ROC. Exploratory factor analysis (EFA) was 
first conducted with the same dataset, to explore whether 
the data would replicate either the one, two, or three-
factor solutions previously reported. The EFA yielded 
a three-factor solution, which we have labelled distress, 
anxiety, and social function. This model was further 
tested in the subsequent CFA. Consistent with previ-
ous EFA analysis, the principal components method was 
used, with orthogonal (Varimax) rotation. Following the 
EFA, four models were tested for goodness of fit (CFA):
1. Three-dimensional: as indicated by the EFA, the 
GHQ-12 was modelled as a measure of three latent 
variables (distress, anxiety, and social function).
2. One-dimensional: the GHQ-12 was modelled as a 
measure of one construct (psychiatric morbidity) 
using all 12 items. The model indicates one latent 
variable with twelve indicator variables, each with its 
own error term.
3. Two-dimensional: the GHQ-12 was modelled as a 
measure of two latent variables (psychological dis-
tress and social dysfunction) as found in a previ-
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ous validation study in Indonesia [38]. The model 
indicates items 2, 5, 6, 9, 10, and 11 correspond to 
psychological distress, while the rest correspond to 
social dysfunction.
4. One-dimensional with correlated errors: the GHQ-
12 was modelled as a measure of one construct but 
with correlated error terms on the negatively phrased 
items, modelling response bias [44]. This model is 
identical to model 2, but with correlations specified 
between the error terms on the negatively phrased 
items.
Following the CFA, a ROC analysis was conducted. The 
required sample size for a prospective ROC study of a 
single diagnostic test [45] allowing a type I error of 0.05 
and a power of 0.80, with the more conservative AUC1 of 
0.80, AUC0 of 0.70, and the allocation ratio of 4 (preva-
lence of common psychiatric disorders is estimated to be 
20% in the primary care population, thus the prevalence 
of non-diseased is estimated at 80%) was 370 subjects (74 
clinically confirmed cases and 296 clinically confirmed 
non-cases).
The ROC curve analysis is a commonly used method 
for visualising performance ability and grouping classifi-
cation [46]. The ROC analysis plots a test’s true positive 
rate (sensitivity) against its false positive rate (1-speficity) 
[47]. The area under a ROC curve represents the prob-
ability that a randomly chosen subject is correctly rated 
or ranked with greater suspicion than a non-diseased 
subject [48]. The area under the curve (AUC) ranges 
from 0.5 for models with no discrimination ability, to 1 
for models with perfect discrimination ability [49]. A 
ROC curve that is near the point of perfect classification 
(upper left corner of the ROC space) is considered supe-
rior for detection performance [50].
In addition, the positive predictive value (PPV) 
describes the proportion of all positive results that 
are correct; while the negative predictive value (NPV) 
describes the proportion of all negative results that are 
correct. These predictive values are dependent on the 
prevalence of mental disorders in the study sample [51].
Total GHQ-12 scores were utilised as the test variable 
for the ROC analysis. The gold standard against which 
the GHQ-12 was tested was the presence of diagnosis fol-
lowing an in-depth psychiatric interview using the CIS-R. 
Two-by-two contingency tables were created by cross-
tabulating diagnostic outcomes (the presence or absence 
of any mental disorders) and the GHQ-12 screening out-
comes (positive or negative screening on the GHQ-12).
Pilot study and focus group discussion
The pilot study was conducted over a period of 1 week 
in June 2016. Trained and vetted research asistants 
checked in for duty every morning at 7 a.m. A tally 
of the number of screenings completed was checked 
against Puskesmas attendance at the end of every day, 
which enabled the calculation of the percentage of 
adult primary care attendees screened. In total, 5341 
patients were screened within the pilot period.
At the end of the pilot, stakeholders who were 
involved in the screening process and a psychiatrist 
(expert in cultural psychiatry) were invited to partici-
pate in a focus group discussion (FGD) to discuss the 
challenges of implementing the screening procedure, 
scoring, operational burden, and informing patients of 
the outcomes. In total, six GPs and research assistants 
participated in the FGD, which took place in September 
2016. The FGD was semi-structured and explored the 
following topics:
• Primary care patients’ comprehension of the 
screening questionnaire;
• Feasibility of the screening procedure according to 
the flow of patients in the clinics;
• Common issues encountered during the screening 
process;
• General feedback about providing mental health 
services in primary care.
As two GPs declined to have the FGD recorded, a 
researcher was taking notes during the FGD process. 
The notes were discussed with other co-authors and 
analysed for the purpose of ensuring the feasibility of 
the screening process.
During the FGD, it became clear that while the 
screening procedure largely worked, older patients 
required help with reading the screening question-
naire. Patients picked up the screening questionnaire 
alongside a queue number at the registration coun-
ter, filled the questionnaire while waiting for routine 
blood pressure check (all adult patients are required 
to pass through the blood pressure counter). A staff 
nurse checking patients’ blood pressure could assess 
the screening questionnaire visually as the GHQ scor-
ing method (0-0-1-1) required no advanced arithmetic. 
The clinics generally had difficulty keeping their pens 
as patients accidentally took them home. It was evident 
that GPs required between 20 and 60  min more with 
each patient who screened positive, creating a long 
queue in the waiting rooms. GPs reported that as they 
get used to asking patients about their mental health 
symptoms, the additional interviews could become 
quicker. When patients were asked to return for an 
in-depth psychiatric interview at a later date, unfortu-
nately most did not return.
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Results
Sample characteristics
Participants were aged between 18 and 82  years old 
(median 46). From the 2532 primary care patients 
approached, 676 consented to participate (452 women; 
224 men). Median and interquartile range for women 
were 2 and 4, and for men 2 and 3. The difference in 
median scores between women and men was not signifi-
cant (Mann–Whitney U = 47,981.50, p = 0.253).
The table below presents participants’ demographic 
characteristics (age, marital status, education level), as 
well as their GHQ-12 scores by gender.(Table 2).
Almost one in five (19%) had only completed elemen-
tary-level education. A further 21% completed Jun-
ior High School, and 37.9% completed a high school 
diploma. The rest (22.1%) completed undergraduate or 
postgraduate degrees. Fewer than 5% received less than 
6 years of formal education.
Table  3 shows the prevalence of ICD-10 psychiatric 
diagnoses and GHQ-12 median scores for adult Indo-
nesian primary care patients. For those with a severe 
depressive episode, the GHQ-12 median score was 10, 
with an interquartile range of 7. For those with Comorbid 
Anxiety and Depression, the GHQ-12 median score was 
3, with an interquartile range of 3. For those with general 
anxiety disorder the GHQ-12 median score was 6, with 
an interquartile range of 9.
Median scores for those with a diagnosis (cases) com-
pared to those who do not meet the ICD-10 diagnostic 
criteria (non-cases) are shown in Table 4.
Table 2 Total and by gender socio-demographic characteristics and GHQ-12 scores (0-0-1-1 scoring)
Women (N = 452) Men (N = 224) Total (N = 676)
N % N % N %
 Age (11 missing)
  18–29 117 26.2 47 21.4 164 24.7
  30–39 62 13.9 24 11.0 86 12.9
  40–49 118 26.5 28 12.8 146 22.0
  50–64 119 26.7 81 37.0 200 30.0
  65+ 30 6.7 39 17.8 69 10.4
 Marital status (2 missing)
  Unmarried 77 17.1 54 24.1 131 19.4
  Married 319 71.1 163 72.8 482 71.7
  Separated/Divorced/Wid-
owed
53 11.8 7 3.1 60 8.9
 Education (6 missing)
  Elementary 94 21.0 33 14.9 127 19.0
  Middle school 104 23.2 43 19.4 147 21.9
  High school 157 35.0 97 43.6 254 37.9
  Diploma 20 4.5 16 7.2 36 5.4
  University 48 10.7 27 12.2 75 11.2
  Others 25 5.6 6 2.7 31 4.6
 GHQ-12 Score
  Median (IQR) 2.00 (4.00) 2.00 (3.00) 2.00 (4.00)
Table 3 Total and  by  gender prevalence of  psychiatric 
diagnoses and  median GHQ-12 scores (bimodal scoring) 
of respondents interviewed with CIS-R and further clinical 
interviews
ICD-10 diagnoses Men Women Total GHQ-12
N (%) N (%) N (%) Median (IQR)
Mild depressive episode 7 (1.0) 29 (4.3) 36 (5.3) 2 (3)
Moderate depressive 
episode
1 (0.1) 11 (1.6) 12 (1.8) 7 (4)
Severe depressive 
episode
1 (0.1) 4 (0.6) 5 (0.7) 10 (7)
Mixed anxiety and 
depression
31 (4.6) 71 (10.5) 102 (15.1) 3 (3)
General anxiety disorder 7 (1.0) 18 (2.7) 25 (3.7) 6 (2)
Panic disorder 5 (0.7) 15 (2.2) 20 (3.0) 5 (6)
Social phobia 7 (1.0) 13 (1.0) 20 (3.0) 2 (1)
Agoraphobia 1 (0.1) 0 (0.0) 1 (0.1) 2 (0)
Specific isolated phobia 2 (0.3) 6 (0.9) 8 (1.2) 3.5 (2)
Obsessive compulsive 
disorder
0 (0.0) 3 (0.4) 3 (0.4) 5 (0)
Diagnosis of other 
disorders
15 (2.2) 54 (8.0) 69 (10.2) 2 (3)
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The GHQ-12 median for cases (48%) was 3, with an 
interquartile range of 3, and the median for non-cases 
was 1, with an interquartile range of 2. The group meet-
ing diagnostic criteria had significantly higher median 
scores than those without diagnosis (Mood’s Median Test 
χ2 = 111.07, df = 1, p < 0.001).
Reliability
The Cronbach’s alpha of the GHQ-12 for bimodal scoring 
(0-0-1-1) was 0.76, indicating satisfactory internal con-
sistency. Inter-rater reliability was not applicable as the 
GHQ-12 was self-completed by patients. Test–retest reli-
ability was not conducted for this study.
Factor analyses
Table  5 shows the Pearson correlation coefficient for 
all items. EFA (principal components analysis with 
Varimax rotation) suggested a three-factor solution 
explaining 48.0% of the total variance in items (factor 1 
eigenvalue = 3.4, factor 2 eigenvalue = 1.3, and factor 3 
eigenvalue = 1.1). We label the factors distress, anxiety, 
and social function.
Table  6 shows the rotated component matrix for all 
items.
Maximum Likelihood Estimation was used to estimate 
the fit of the four models (Table 7). None of the models 
are considered good fitting models based on the Normed 
Fit Index and Comparative Fit Index (Figs. 1, 2, 3, 4), as 
none of them exceed 0.95 or 0.93 respectively [52].
Based on the Root Mean Square Error of Approxima-
tion (RMSEA), Model 1 was found to be an acceptable 
fit, while based on the Expected Cross-Validation Index 
(ECVI), Model 4 is an acceptable fit. Considering all 
goodness of fit indices, Model 4 was found to be the best 
of all the options.
Model 1: The three-factor model indicated by the EFA 
was further examined by CFA below.
Model 2: The one-dimensional model according to the 
theoretical underpinning of the GHQ-12 was examined 
by CFA below.
Model 3: The two-dimensional model previously found 
in the Indonesian version with Likert scoring [38].
Model 4: The one-dimensional model with correlated 
errors [44].
Table 4 GHQ-12 mean and median scores for non-cases vs. cases meeting any ICD-10 diagnostic criteria during sampling 
period, Bimodal scoring (0-0-1-1)
Women Men All
N N N
 Mean (SD)
  Cases 3.70 (2.66) 235 3.61 (2.64) 89 3.68 (2.65) 324
  Non-cases 1.40 (1.79) 216 1.21 (1.58) 135 1.33 (1.71) 351
 Median (IQR)
  Cases 3 (3) 235 3 (3) 89 3 (3) 324
  Non-cases 1 (2) 216 1 (2) 135 1 (2) 351
Table 5 Pearson Correlation Matrix between all items
GHQ2 GHQ3 GHQ4 GHQ5 GHQ6 GHQ7 GHQ8 GHQ9 GHQ10 GHQ11 GHQ12
GHQ1 0.242 0.194 0.185 0.231 0.175 0.184 0.198 0.127 0.256 0.104 0.180
GHQ2 1.000 0.087 0.115 0.185 0.162 0.193 0.219 0.167 0.178 0.124 0.165
GHQ3 1.000 0.266 0.066 0.187 0.217 0.179 0.117 0.177 0.118 0.158
GHQ4 1.000 0.094 0.152 0.197 0.306 0.101 0.232 0.140 0.193
GHQ5 1.000 0.308 0.162 0.217 0.363 0.239 0.231 0.288
GHQ6 1.000 0.158 0.466 0.302 0.356 0.271 0.248
GHQ7 1.000 0.264 0.213 0.122 0.081 0.201
GHQ8 1.000 0.216 0.255 0.223 0.265
GHQ9 1.000 0.331 0.300 0.446
GHQ10 1.000 0.496 0.293
GHQ11 1.000 0.287
GHQ12 1.000
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Validity coefficients and area under the ROC curve
The threshold values, sensitivity, specificity, PPV, NPV, 
and AUC of the GHQ-12 based on diagnostic groups (at 
2-week prevalence) are summarised in Table 8.
The ROC analysis indicated that the optimal cut-off 
point for the identification of any diagnosis was 1/2. 
Sensitivity was 82% while specificity was 64%. The AUC 
of 0.79 indicates that GHQ-12 is ‘fairly accurate’. The 
traditional established point system for the AUC speci-
fies that AUC of at least 0.70 is required to ensure fair 
accuracy [51]. The ROC curve for any ICD-10 diag-
nosis is presented in Fig.  5. A logistic regression was 
conducted to predict diagnostic outcome with GHQ-
12 screening threshold of 1/2 as a predictor variable. 
Primary care patients who screened positive based on 
this threshold have 7.52-fold higher odds of receiving a 
CIS-R diagnosis (95% CI 3.72–15.20, p < 0.001). Apply-
ing this threshold score of ≥ 2 for a further 2  weeks 
Table 6 Rotated component matrix for  exploratory factor 
analysis
Extraction Method: Principal Component Analysis (Items loading on the factos 
are indicated in Italics.)
Rotation Method: Varimax with Kaiser Normalization
Rotation converged in 7 iterations
Factor 1 Factor 2 Factor 3
GHQ1 0.11 0.54 0.26
GHQ2 0.11 0.66 0.02
GHQ3 0.06 0.12 0.68
GHQ4 0.11 0.10 0.72
GHQ5 0.50 0.47 − 0.18
GHQ6 0.55 0.20 0.26
GHQ7 0.03 0.58 0.31
GHQ8 0.34 0.32 0.45
GHQ9 0.66 0.31 − 0.11
GHQ10 0.70 − 0.02 0.29
GHQ11 0.75 − 0.16 0.16
GHQ12 0.57 0.30 0.06
Table 7 The factor structure of the twelve-item General Health Questionnaire (GHQ-12)
NFI Normed Fit Index, CFI Comparative Fit Index, RMSEA Root Mean Square Error of Approximation, ECVI Expected Cross Validation Index
Model Χ2 df p Χ2/df NFI CFI RMSEA (90% CL) ECVI (90% CL)
1. Three-dimensional 249.10 51 0.000 4.88 0.821 0.849 0.076 0.485
2. One-dimensional 322.78 54 0.000 5.98 0.785 0.795 0.086 0.585
3. Two-dimensional 298.90 53 0.000 5.64 0.785 0.813 0.083 0.552
4. One-dimensional with 
correlated error terms
212.60 39 0.000 5.45 0.847 0.868 0.081 0.466
Fig. 1 Confirmatory Factor Analysis of three-factor model
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of screening (as part of the recruitment of a trial [9] 
resulted in the identification of 574 patients who met 
the screening criteria from 2320 primary care patients 
screened (24.7%).
Discussion
The GHQ-12 was found to have good inter-item consist-
ency when used in the Indonesian primary care setting. 
CFA supports a one-dimensional model with correlated 
Fig. 2 Confirmatory Factor Analysis of a one-dimensional model
Fig. 3 Confirmatory Factor Analysis of a two-dimensional model
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error terms for negatively phrased items which account 
for response bias. The GHQ-12 is also a ‘fairly accurate’ 
screening tool with a predictive power for ICD-10 psy-
chiatric diagnosis of nearly 0.8 (AUC = 0.78). The rec-
ommended optimal threshold differs depending on the 
objectives for using the GHQ-12. For use in Puskesmas, 
the goal can be to comprehensively screen for any ICD-
10 psychiatric diagnosis even at the risk of a high false 
positive rate. As such, the optimal threshold for the 
bimodal scoring is 1/2 points. If the goal is for better dis-
crimination of mood disorders and anxiety disorders [15] 
it may be more appropriate to adopt the more stringent 
threshold of 2/3 points.
While for practicality, a more conservative cut-off score 
will reduce the absolute number of psychiatric interviews 
to be conducted, one must critically form a decision with 
the awareness that there are people who would other-
wise be diagnosed, who did not meet the screening crite-
ria (False Negatives). Using a cut-off score of 2, the False 
Negative Rate is 20%, while with a more conservative cut-
off score of 3, the False Negative Rate is 31%. If the goal of 
screening for psychiatric disorders in primary care is to 
help bridge Treatment Gap, the recommended threshold 
is 1/2 points, where a score of 2 or above is ‘positive’ for 
at risk of psychiatric disorders.
The medians of participants with psychiatric diagnosis 
[4] and those without [1], shows that while the difference 
of one or two scores may seem trivial, it was sufficient 
to highlight potential ‘cases’ from other primary care 
patients. The use of a ‘fairly accurate’ screening tool 
within clinical setting would facilitate the swift identifica-
tion of primary care patients at risk of psychiatric mor-
bidity, bolstering the confidence of primary care doctors 
to conduct in-depth psychiatric interview without fear 
of making a mistake or offending their patients. Patients 
who screened positive for indication of mental health 
problems using this threshold score was found to be 7.52 
times more likely to get a diagnosis compared to those 
who did not screen positive.
The analysis indicates that the Indonesian version of 
the GHQ-12 may be used to screen for mental health 
problems among primary care patients. For clinical ser-
vices, an optimal threshold score for any tool used in 
screening for mental disorders is necessary to best dis-
tinguish at-risk individuals from the remaining popula-
tion [53]. A screening tool such as the GHQ-12 may have 
Fig. 4 Confirmatory Factor Analysis of one-dimensional model with 
correlated error terms
Table 8 Performance and ROC area of the GHQ-12 (bimodal scoring)
SE Sensitivity, SP Specificity, PPV Positive Predictive Value, NPV Negative Predictive Value, AUC Area Under Curve
ICD-10 diagnoses Threshold SE SP PPV NPV AUC 
Mood disorders 1/2 0.774 0.433 0.104 0.957 0.702
2/3 0.717 0.634 0.143 0.963
Mixed anxiety and depression 1/2 0.902 0.474 0.234 0.965 0.725
2/3 0.686 0.659 0.263 0.922
Anxiety disorders 1/2 0.805 0.446 0.157 0.947 0.661
2/3 0.597 0.624 0.172 0.924
Any diagnosis 1/2 0.824 0.641 0.679 0.789 0.787
2/3 0.599 0.798 0.732 0.683
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great utility within primary care in Indonesia, particu-
larly as it may have the potential to increase efficiency 
within an overburdened healthcare system. It could 
only be introduced, however, if the effective services to 
support those screened are in place [54], i.e. in primary 
care clinics which provide mental health services. Those 
who screened positive should be provided additional 
information regarding common mental health problems 
[55]. It could be argued that screening played a key role 
in identifying patients with indication of mental health 
problems in the trial we conducted in Indonesia, at very 
little additional costs to the health systems as screen-
ing was embedded into routine procedure [9]. With 
service expansion planned to reach all 10,000 primary 
care clinics, policy makers should consider encourag-
ing screening for mental health problems to help clini-
cians quickly identify patients at risk. Screening, coupled 
with increased mental health literacy could facilitate the 
early identification and intervention of mental disorders, 
which would help bridge Indonesia’s enormous Treat-
ment Gap.
This study’s strength lies in its validation of the utility of 
the GHQ-12 in Indonesia’s primary care setting, however, 
it is not without its limitations. While this study con-
firms the efficacy of the Indonesian version of the GHQ-
12 for the Indonesian primary care population, it is not 
necessarily generalisable for whole populations for gen-
eral screening, as our sample is limited to primary care 
attendees. Another limitation is the wide range of mental 
health disorders captured by the CIS_R and the relatively 
small number of patients which fall into each of the cat-
egory (Table  3). This makes it impossible to ascertain if 
the GHQ-12 was better for screening a specific type of 
disorder compared to others. Additionally, test–retest 
reliability was not assessed, further limiting the general-
isability of the results. It should be noted that although 
the GHQ-12 identifies at-risk individuals, to establish an 
ICD-10 diagnosis requires a full psychiatric interview 
with qualified clinicians. Further research into the utility 
of the GHQ-12 in accurately screening for mental disor-
ders among the non-primary care population should be 
attempted.
The length of waiting time means more patients who 
agreed to take part in the study left before completing the 
standardised psychiatric interviews, due to other com-
mitments such as work. This is reflected in the smaller 
number of men participating in the study (n = 224) com-
pared to women (n = 452). Women have been shown to 
be more willing to access mental health services than 
men [56, 57].
If screening were to be implemented across primary 
care clinics in Indonesia, it is possible its impact would be 
viewed with concern. Understandably, in clinics with sig-
nificantly less resources, manpower is limited. Increased 
consultation time, increased waiting time, and possibly 
increased working hours for clinicians are but some of 
the issues anticipated, which might affect the accept-
ability of screening. As this study took place in real life 
settings, we observed that medical consultations, includ-
ing the standardised psychiatric interview, took between 
20 to 60  min longer depending on the complexity and 
severity of symptoms to be addressed. At some clinics, 
patients meeting the screening criteria were asked to wait 
for all other patients to have their consultations, draw-
ing strong criticisms from patients who had to wait hours 
for their consultations. In other clinics, one GP on duty 
was assigned to handle all patients requiring a psychiatric 
interview, while all other patients had consultations with 
other GPs–a seemingly more realistic pathway.
Conclusions
This study indicates that the Indonesian version of the 
GHQ-12 is feasible for use as a screening tool for men-
tal health problems among primary care patients. The 
benefits of screening for mental disorders in primary 
care must be weighed against other practical considera-
tions. Nonetheless, in Indonesia, where the Treatment 
Gap for mental disorders is above 95% [3], the benefits 
could potentially outweigh the additional burden on 
the health system.
Fig. 5 ROC curve of GHQ-12 for ICD-10 psychiatric diagnoses. 
Bimodal scoring 0-0-1-1
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